FDA Drug · D-0195-2025

Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma Inc., Fairfield, NJ 07034, NDC 71399-8014-01.

Class III · Ongoing

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Affected lots / codes — check yours against thisLot #s: KDT0124004, KDT0124005, KDT0124006, Exp 08/31/2026

Recalling firm: Akron Pharma, Inc., Fairfield, NJ
Classification: Class III (unlikely to cause harm)
Status: Ongoing
Quantity: 14825 bottles
Distribution: Nationwide in the US
Recall initiated: December 12, 2024
Classified: January 10, 2025
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0195-2025%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →